 FSD Pharma Inc CSE:HUGE, NASDAQ:HUGE said its board of directors has approved a share repurchase program that will allow the company to buy back up to 1.9 million of its subordinate Class B voting shares over the next 12 months. FSD Pharma is focused on the advancement of its drug candidates toward the clinic, and we recognize there may be a strategic opportunity to enhance shareholder value without compromising our ambitious growth plans, the companys interim CEO Anthony Durkacz said in a statement. 